Nurix Therapeutics, Inc.
NRIXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Nurix Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Nov 30, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Rockefeller Capital Management L.P. | 2026-03-31 | 5,318 | $82.4K | SEC filing |
| Amova Asset Management Americas, Inc. | 2026-03-31 | 1,181,146 | $18.3M | SEC filing |
| 49 WEALTH MANAGEMENT, LLC | 2026-03-31 | 10,018 | $155K | SEC filing |
| ArrowMark Colorado Holdings LLC | 2026-03-31 | 314,762 | $4.88M | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 223,363 | $3.46M | SEC filing |
| SG Americas Securities, LLC | 2026-03-31 | 18,974 | Not shown | SEC filing |
| Hughes Financial Services, LLC | 2026-03-31 | 3 | $47 | SEC filing |
| Trexquant Investment LP | 2026-03-31 | 209,694 | $3.25M | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 15,400 | $239K | SEC filing |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2026-03-31 | 90,000 | $1.4M | SEC filing |
| TD Asset Management Inc | 2026-03-31 | 189,250 | $2.93M | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 438 | $6.79K | SEC filing |
| Torren Management, LLC | 2026-03-31 | 59 | $915 | SEC filing |
| EverSource Wealth Advisors, LLC | 2026-03-31 | 10 | $155 | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 4,931,999 | $76.4M | SEC filing |
| Deep Track Capital, LP | 2026-03-31 | 6,345,244 | $98.4M | SEC filing |
| AlphaCentric Advisors LLC | 2026-03-31 | 25,571 | $396K | SEC filing |
| QUADRANT CAPITAL GROUP LLC | 2026-03-31 | 344 | $5.33K | SEC filing |
| Handelsbanken Fonder AB | 2026-03-31 | 547,000 | Not shown | SEC filing |
| SIMPLEX TRADING, LLC | 2026-03-31 | 8,113 | $126K | SEC filing |
- Each value is checked against Nurix Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Nurix Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Nurix Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-25 · Ring Christine: Larger than 50 of the 51 other insider sales of Common Stock on file. SEC filing
- 2026-05-05 · van Houte Hans: Larger than 48 of the 51 other insider sales of Common Stock on file. SEC filing
- 2026-02-09 · Ring Christine: Larger than 49 of the 51 other insider sales of Common Stock on file. SEC filing
- 2025-11-24 · Ring Christine: Larger than all 51 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-25 | Ring Christine · Chief Legal Officer | Common Stock | S — Open market or private sale | −28,935 | 20.06 | SEC filing |
| 2026-06-25 | Hansen Gwenn · Chief Scientific Officer | Common Stock | S — Open market or private sale | −5,394 | 20.00 | SEC filing |
| 2026-06-02 | Ring Christine · Chief Legal Officer | Common Stock | S — Open market or private sale | −8,148 | 16.60 | SEC filing |
| 2026-05-05 | van Houte Hans · Chief Financial Officer | Common Stock | S — Open market or private sale | −582 | 17.18 | SEC filing |
| 2026-05-05 | van Houte Hans · Chief Financial Officer | Common Stock | S — Open market or private sale | −13,473 | 16.58 | SEC filing |
| 2026-05-04 | Ring Christine · Chief Legal Officer | Common Stock | S — Open market or private sale | −8,148 | 16.96 | SEC filing |
| 2026-05-01 | Ring Christine · Chief Legal Officer | Common Stock | S — Open market or private sale | −5,394 | 16.76 | SEC filing |
| 2026-04-30 | van Houte Hans · Chief Financial Officer | Common Stock | S — Open market or private sale | −2,388 | 16.65 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Ring Christine · Chief Legal Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −13,333 | SEC filing |
| 2026-06-25 | Ring Christine · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +13,333 | SEC filing |
| 2026-06-25 | Ring Christine · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +15,602 | SEC filing |
| 2026-06-25 | Ring Christine · Chief Legal Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −15,602 | SEC filing |
| 2026-06-02 | Ring Christine · Chief Legal Officer | Employee Stock Option (right to buy) | M — Exercise or conversion of derivative security | −3,422 | SEC filing |
| 2026-06-02 | Ring Christine · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +3,422 | SEC filing |
| 2026-05-15 | Reinsdorf Judith A · Director | Director Stock Option (right to buy) | A — Grant, award, or other acquisition | +31,250 | SEC filing |
| 2026-05-15 | Baynes Roy D. · Director | Director Stock Option (right to buy) | A — Grant, award, or other acquisition | +31,250 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.